The Use of Art Therapy in Complex Treatment on the Quality of Remission in Patients with Melancholy in Major Depressive Disorder

生活质量(医疗保健) 萧条(经济学) 药物治疗 焦虑 重性抑郁障碍 完全缓解 医学 精神科 心理学 心理治疗师 内科学 化疗 认知 经济 宏观经济学
作者
Hanna Kozhyna,V. Korostiy,S. Hmain,V. Mykhaylov
出处
期刊:European Psychiatry [Cambridge University Press]
卷期号:41 (S1): s777-s777 被引量:2
标识
DOI:10.1016/j.eurpsy.2017.01.1473
摘要

Introduction According to studies done in recent years regarding the treatment of patients with melancholy in major depressive disorder, a shift of interest from studies evaluating the effectiveness of therapy to the study of remission is seen. Despite significant progress in the development of pharmacotherapy of depressive disorders, difficulty in achieving rapid reduction in depressive symptoms and stable remission in patients with melancholic depression necessitated the search for new approaches to the treatment of this pathology. Aims Evaluating the effectiveness of art therapy in treatment in patients with melancholy in major depressive disorder on the quality of remission. Methods The study involved 135 patients – 60 male and 75 female patients aged from 18 to 30 years old. The main group of patients apart the combined treatment also participated in group art therapy with the use of drawing techniques, while the control group – statutory standard therapy. Results The results of the use of art therapy in complex treatment in patients with major depressive disorder is detected primarily in reducing of the level of anxiety at the early stages of treatment (60% of patients have noticed decreasing of melancholic state), as well as improving the quality of life in remission period. Conclusion These results support the use of art therapy in treatment in patients with melancholy in major depressive disorder during period of active treatment, and after achieving clinical remission contributes to achieving and maintaining high-quality and stable remission with full restoration of quality of life and social functioning. Disclosure of interest The authors have not supplied their declaration of competing interest.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
wsws发布了新的文献求助10
刚刚
Depeng完成签到,获得积分10
刚刚
LL完成签到,获得积分10
刚刚
似风完成签到,获得积分10
1秒前
Morii完成签到,获得积分10
1秒前
淡定的安白完成签到,获得积分10
1秒前
酷酷完成签到,获得积分10
1秒前
1秒前
yangyangyang完成签到,获得积分10
2秒前
zhouzhou完成签到,获得积分10
2秒前
无限梦蕊完成签到,获得积分10
2秒前
SCI完成签到,获得积分10
3秒前
合适的如天完成签到,获得积分10
3秒前
狗宝完成签到,获得积分10
3秒前
4秒前
寒赤月完成签到,获得积分10
4秒前
小明同学完成签到,获得积分10
4秒前
4秒前
崔同学发布了新的文献求助10
4秒前
追梦发布了新的文献求助10
5秒前
shouyu29发布了新的文献求助10
5秒前
俊逸芒果完成签到,获得积分20
6秒前
Gt完成签到,获得积分10
6秒前
从容宛筠完成签到,获得积分20
6秒前
啦啦啦啦啦完成签到 ,获得积分10
6秒前
问道旗山完成签到 ,获得积分10
6秒前
zink完成签到,获得积分10
7秒前
wsws完成签到,获得积分10
7秒前
kk完成签到,获得积分10
7秒前
hzt完成签到,获得积分10
7秒前
EL完成签到,获得积分10
7秒前
肥牛发布了新的文献求助10
8秒前
靓丽的采白完成签到,获得积分10
8秒前
田小豪完成签到,获得积分10
8秒前
以七完成签到 ,获得积分10
8秒前
8秒前
唯一完成签到,获得积分20
8秒前
好运偏爱的那个男的完成签到,获得积分10
9秒前
Chosen_1完成签到,获得积分10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Principles of town planning : translating concepts to applications 500
Social Work and Social Welfare: An Invitation(7th Edition) 410
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6059416
求助须知:如何正确求助?哪些是违规求助? 7891983
关于积分的说明 16298703
捐赠科研通 5203615
什么是DOI,文献DOI怎么找? 2783979
邀请新用户注册赠送积分活动 1766692
关于科研通互助平台的介绍 1647203